Acute liver injury and octreotide

American Journal of Gastroenterology

Volumn 91, Issue 11, 1996, Pages 2434-2435

  Gonzalez Martin J A ^a   Donnay, S ^a   Morillas, J ^a   Gomez Aparicio C ^a   Garcia Cano, J ^a   Perez Vigara G ^a   Roldan A ^a  

^a HOSPITAL VIRGEN DE LA LUZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; OCTREOTIDE;

ACROMEGALY; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HORMONE INHIBITION; HUMAN; HYPOPHYSIS ADENOMA; LIVER CELL DAMAGE; PRIORITY JOURNAL; TRANSSPHENOIDAL HYPOPHYSECTOMY; TREATMENT FAILURE; TREATMENT OUTCOME;

ACROMEGALY; ADENOMA; ANTINEOPLASTIC AGENTS, HORMONAL; FEMALE; HEPATITIS, TOXIC; HUMANS; MIDDLE AGED; OCTREOTIDE; PITUITARY NEOPLASMS;

EID: 0029847851     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Gorden P, Comi RJ, Maton PN, et al. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Ann Intern Med 1989;110:35-50.
2. Lamberts SWJ, Van der Lely AJ, de Herder WW, et al. Drug therapy: Octreotide. N Eng J Med 1996;334:246-54.
3. Grosman I, Simon D. Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide. Am J Gastroenterol 1990;85: 1061-72.
4. Mosdell KW, Visconti JA. Emerging indications for octreotide therapy. Am J Hosp Pharm 1994;51:1184-92 (part 1),
5. Mosdell KW, Visconti JA. Am J Hosp Pharm 1317-30 (part 2).
6. Redfern JS, Fortuner II WJ. Octreotide-associated biliary tract dysfunction and gallstones formation: Pathophysiology and management. Am J Gastroenterol 1995;90:1042-52.
7. Montini M, Salmoiraghi M, Pagani MD, et al. Somatostatin octapeptide analogue in the treatment of acromegaly: Experience in 16 patients. J Endocr Invest 1987;10:92.
8. Primrose JN, Bramley P, Johnston D. The use of octreotide (SMS 201-995) in the treatment of intractable dumping after vagotomy or gastrectomy. Gastroenterology 1988;94:A360.
9. Fanning M, Monte M, Sutherland LR, et al. Pilot study of sandostatin (octreotide) therapy of refractary HIV-associated diarrhea. Dig Dis Sci 1991;36:476-80.
10. Ezzat S, Snyder PJ, Young WF, et al. Octreotide treatment of acromegaly: A randomized, multicenter study. Ann Intern Med 1992;117: 711-8.
11. Bruin TWA, Kwekkeboom DJ, Van't Verlaat JW, et al. Clinically nonfunctioning pituitary adenoma and octreotide response to long-term high dose treatment and studies in vitro. J Clin Endocrinol Metab 1992;75:1310-17.
12. Aroisio M, Bazzoni N, Ambrosi B, et al. Acute hepatitis after treatment of acromegaly with octreotide. Lancet 1988;2:1498.
13. Criteria of drug-induced liver disorders: Report of an international consensus meeting. J Hepatol 1990;11:232-6